Role of P2Y1 purinoceptor in ADP‐induced platelet activation
Open Access
- 19 February 1998
- journal article
- Published by Wiley
- Vol. 422 (3) , 291-295
- https://doi.org/10.1016/s0014-5793(98)00025-8
Abstract
ADP acts as an agonist of platelet aggregation via specific receptors which are still to be characterised. Amplification by PCR of a human platelet cDNA library confirmed the presence of mRNA of the ...Keywords
This publication has 26 references indexed in Scilit:
- Effect of clopidogrel treatment on ADP‐induced phosphorylations in rat plateletsBritish Journal of Haematology, 1997
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Cloning and Tissue Distribution of the Human P2Y1ReceptorBiochemical and Biophysical Research Communications, 1996
- Cloning and Chromosomal Localization of the Human P2Y1 PurinoceptorBiochemical and Biophysical Research Communications, 1996
- Clopidogrel, A Novel Antiplatelet and Antithrombotic AgentCardiovascular Drug Reviews, 1993
- Cytoplasmic free Ca2+ in human platelets: Ca2+ thresholds and Ca‐independent activation for shape‐change and secretionFEBS Letters, 1982
- Synergistic responses and receptor occupancy in rabbit blood plateletsThrombosis Research, 1982
- Extraction of cyclic amp for the determination in the competitive protein binding assayClinica Chimica Acta; International Journal of Clinical Chemistry, 1980
- Effect of aggregating agents and their inhibitors on the mean platelet shapeJournal of Clinical Pathology, 1966
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962